# LENALIDOMIDE

NDC: 0574-1402
Generic name: lenalidomide
Labeler / Manufacturer: Padagis US LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20260131

FDA application: ANDA217265

## Active ingredients

- LENALIDOMIDE: 2.5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0574-1402"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0574-1402
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dffe719b-4f61-47e2-b71c-673322d487f5